Integrity CE

 

 

Integrity CE
M

Health Disparities in Endometrial Cancer

By Integrity CE FEATURING Martina Murphy
By Integrity CE FEATURING Martina Murphy
17 views
September 7, 2023
0 Comments
Login to view comments. Click here to Login
Oncology & Hematology
06:28
Integrity CE

TROP-2 ADCs for the Treatment of HR+/HER2- BC, TNBC, and NSCLC: Adva…

Feat. L. Schwartzberg, J. Porter
03:46
Integrity CE

The Evolving Treatment Journey for Patients With Unresectable Stage …

Feat. T. Leal
03:35
Integrity CE

Case Discussion: 59 y/o Former Smoker With Stage 3A NSCLC

Feat. T. Leal
02:35
Integrity CE

SABCS 2023 Summary: "monarchE & NATALEE Trials - Adjuvant T…

Feat. A. Bardia
03:06
Integrity CE

SABCS 2023 Insights: "KEYNOTE-756 Trial - Pembro vs. Placebo Co…

Feat. M. Lustberg
03:40
Integrity CE

SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & …

Feat. A. Bardia
03:24
Integrity CE

SABCS 2023 Insights: "TROPION-Breast01 - Dato-DXd Compared to C…

Feat. A. Bardia
10:48
Integrity CE

Cervical Chronicles: Navigating the Evolving Landscape of Treatment

Feat. M. Murphy
05:52
Integrity CE

Expert Panel Case Discussion: Stage 4A High-Grade Serous Epithelial …

Feat. M. Murphy, E. Teplinsky, M. Finkel
05:55
Integrity CE

Expert Panel Case Discussion: 45 y/o With Recurrent Stage 3A Platinu…

Feat. M. Murphy, E. Teplinsky, M. Finkel
05:55
Integrity CE

Expert Panel Case Discussion: BRCA+ Epithelial Ovarian Cancer Who Ha…

Feat. M. Murphy, E. Teplinsky, M. Finkel
06:23
Integrity CE

ASH 2023 Insights: "PERSEUS Study - Daratumumab With VRd vs. VR…

Feat. O. Landgren
22:56
Integrity CE

Collaborative Care in MF - Community and Academic Physicians Discuss…

Feat. L. Fletcher, A. Gerds
07:37
Integrity CE

ASH 2023 Insights: "CARTITUDE-2 Updates - Cilta-Cel in Patients…

Feat. S. Usmani
04:09
Integrity CE

SABCS 2023 Summary: "Clinical Updates in HER2+ BC"

Feat. P. Tarantino
02:12
Integrity CE

Health Disparities in Endometrial Cancer

Feat. M. Murphy
04:18
Integrity Continuing Education

Advancing Care for Patients With SCLC

Feat. N. Florez, E. Rodriguez, C. Smith
06:14
Integrity CE

A Brief Review of Ongoing NSCLC Clinical Trials

Feat. J. Gainor, J. Sands
07:46
Integrity Continuing Education

40 y/o Male With Stage 3A NSCLC: Treatment Options

Feat. J. Gainor, J. Sands
04:31
Integrity CE

Neoadjuvant and Adjuvant Treatment in Early Stage NSCLC: Options Are…

Feat. J. Gainor, J. Sands
07:22
Integrity CE

Targeted Treatment of Myelofibrosis: Novel Pathways & Mechanisms…

Feat. R. Mesa, A. Gerds
07:27
Integrity CE

New Frontiers in the Targeted Treatment of Myelofibrosis: Second-Gen…

Feat. R. Mesa, A. Gerds